{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:16:44Z","timestamp":1793380604053,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronavirus disease (COVID-19) currently named SARS-CoV-2 is a contagious disease caused by a coronavirus. The virus may infect the hair follicles directly or indirectly through systemic changes in the immune or hormonal systems.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>In the current study we aimed to determine the prevalence of hair disorders in females infected with COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data was collected using a questionnaire covering four main domains: personal data, past medical history, COVID-19 history and treatment, and existence of any hair problems and their management. No identifier or sensitive data were collected. Those complaining of hair loss were subjected to complete general and local hair examination using trichoscopy to confirm hair loss.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Hair problems were reported in 307 (61.4%) of COVID-19-infected female subjects. A total of 68.1% patients reported that hair loss existed and increased after COVID-19; 29.6% reported their hair problems only post-COVID-19 while 2.3% had hair shedding issues during infection only. The main reported hair problems were telogen effluvium (60.8%), increased gray hair (13.8%), seborrheic dermatitis (5.6%) trichotillomania (3.6%), and alopecia areata (2.2%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion, we reported prevalence of post-COVID hair fall that was confirmed by trichoscopy and which affected approximately 61.4% of infected females.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-023-03509-0","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:25:57Z","timestamp":1694661957000},"page":"761-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study"],"prefix":"10.1007","volume":"193","author":[{"given":"Nehal El Hendawy Ali","family":"Awad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria M.","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-5241","authenticated-orcid":false,"given":"Mohamed L.","family":"Elsaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"2","key":"3509_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jdermsci.2020.04.011","volume":"98","author":"M Sachdeva","year":"2020","unstructured":"Sachdeva M, Gianotti R, Shah M et al (2020) Cutaneous manifestations of COVID-19: report of three cases and a review of literature. J Dermatol Sci 98(2):75\u201381","journal-title":"J Dermatol Sci"},{"issue":"4","key":"3509_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13666","volume":"33","author":"ML Elsaie","year":"2020","unstructured":"Elsaie ML, Youssef EA, Nada HA et al (2020) Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther 33(4):e13666","journal-title":"Dermatol Ther"},{"issue":"1","key":"3509_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","volume":"27","author":"Q Xiong","year":"2021","unstructured":"Xiong Q, Xu M, Li J et al (2021) Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 27(1):89\u201395","journal-title":"Clin Microbiol Infect"},{"key":"3509_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.25122\/jml-2021-0380","volume":"15","author":"S Seyfi","year":"2022","unstructured":"Seyfi S, Alijanpour R, Aryanian Z, Ezoji K, Mahmoudi M et al (2022) Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. J Med Life 15:631\u2013634","journal-title":"J Med Life"},{"issue":"7","key":"3509_CR5","first-page":"1576","volume":"13","author":"GM Iancu","year":"2023","unstructured":"Iancu GM, Molnar E, Ungureanu L et al (2023) SARS-CoV-2 infection\u2014a trigger factor for telogen effluvium: review of the literature with a case-based guidance for clinical evaluation. Life (Basel) 13(7):1576","journal-title":"Life (Basel)"},{"issue":"9","key":"3509_CR6","volume":"14","author":"RA Abdulwahab","year":"2022","unstructured":"Abdulwahab RA, Aldajani BM, Natto NK et al (2022) Prevalence of hair loss after COVID-19 infection in Makkah Region, Saudi Arabia. Cureus 14(9):e29285","journal-title":"Cureus"},{"issue":"10","key":"3509_CR7","volume":"14","author":"S Alkeraye","year":"2022","unstructured":"Alkeraye S, Alrashidi A, Alotaibi NS et al (2022) The association between hair loss and COVID-19: the impact of hair loss after COVID-19 infection on the quality of life among residents in Saudi Arabia. Cureus 14(10):e30266","journal-title":"Cureus"},{"key":"3509_CR8","doi-asserted-by":"crossref","unstructured":"M\u00fcller-Ramos P, Ianhez M, Silva de Castro CC et al (2022) Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. Int J Dermatol 61(5):e162\u2013e164","DOI":"10.1111\/ijd.16041"},{"issue":"1","key":"3509_CR9","doi-asserted-by":"publisher","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","volume":"11","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11(1):16144","journal-title":"Sci Rep"},{"issue":"9","key":"3509_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.876561","volume":"12","author":"AR Mahadi","year":"2022","unstructured":"Mahadi AR, Rafi MA, Shahriar T et al (2022) Association between hair diseases and COVID-19 pandemic-related stress: a cross-sectional study analysis. Front Med (Lausanne) 12(9):876561","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"3509_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13923","volume":"33","author":"D Turkmen","year":"2020","unstructured":"Turkmen D, Altunisik N, Sener S, Colak C et al (2020) Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire. Dermatol Ther 33(6):e13923","journal-title":"Dermatol Ther"},{"issue":"2","key":"3509_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/ijd.16454","volume":"62","author":"\u00d6 Kutlu","year":"2023","unstructured":"Kutlu \u00d6, Demircan YT, Y\u0131ld\u0131z K, Kalkan G, Demirseren DD et al (2023) The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study. Int J Dermatol 62(2):202\u2013211","journal-title":"Int J Dermatol"},{"issue":"8","key":"3509_CR13","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1111\/ijd.16542","volume":"62","author":"Y Abushukur","year":"2023","unstructured":"Abushukur Y, Mansour M, Rehman R, Rida A, Daveluy S et al (2023) A systematic review of hair loss as a consequence of COVID-19 infection. Int J Dermatol 62(8):e436\u2013e439","journal-title":"Int J Dermatol"},{"key":"3509_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40801-015-0056-z","volume":"3","author":"MM Watras","year":"2016","unstructured":"Watras MM, Patel JP, Arya R et al (2016) Traditional anticoagulants and hair loss: a role for direct oral anticoagulants? A review of the literature. Drugs Real World Outcomes 3:1\u20136","journal-title":"Drugs Real World Outcomes"},{"issue":"7","key":"3509_CR15","first-page":"4663","volume":"9","author":"W AlSahli","year":"2022","unstructured":"AlSahli W, Almulhim Y, Issa NT et al (2022) Cross-sectional study to determine the prevalence of telogen effluvium among patients experiencing COVID-19 infection or vaccination in Saudi Arabia and Arabic countries. Eur J Mol Clin Med 9(7):4663\u20134674","journal-title":"European Journal of Molecular & Clinical Medicine"},{"key":"3509_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejim.2020.03.014","volume":"75","author":"G Lippi","year":"2020","unstructured":"Lippi G, Henry BM (2020) Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med 75:107\u2013108","journal-title":"Eur J Intern Med"},{"key":"3509_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejim.2020.04.060","volume":"77","author":"G Lippi","year":"2020","unstructured":"Lippi G, Sanchis-Gomar F, Henry BM et al (2020) Active smoking and COVID-19: a double-edged sword. Eur J Intern Med 77:123\u2013124","journal-title":"Eur J Intern Med"},{"issue":"4","key":"3509_CR18","first-page":"220","volume":"30","author":"D Te\u0161anovi\u0107 Perkovi\u0107","year":"2022","unstructured":"Te\u0161anovi\u0107 Perkovi\u0107 D, Vukojevi\u0107 M, Bukvi\u0107 MZ et al (2022) Post-COVID telogen effluvium. Acta Dermatovenerol Croat 30(4):220\u2013226","journal-title":"Acta Dermatovenerol Croat"},{"key":"3509_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-023-03493-5","author":"AM Ammar","year":"2023","unstructured":"Ammar AM, Ibrahim IS, Mohamed AN, Elsaie ML et al (2023) Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study. Ir J Med Sci. https:\/\/doi.org\/10.1007\/s11845-023-03493-5","journal-title":"Ir J Med Sci"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03509-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T04:00:34Z","timestamp":1711339234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03509-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03509-0","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by ethics committee on human research by Al Azhar Faculty of Medicine IRB (00012367-21-06-005). All methods were performed in accordance with the relevant guidelines and regulations. Written informed consents were received from participants upon explanation of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The manuscript does not contain any individual personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}